Oxurion NV, a pharmaceutical contract manufacturing group based mostly in Leuven, has introduced €30 million in funding to spend money on digital property. This sum, obtained by means of an settlement with Atlas Capital Markets, is split into 12 tranches of convertible bonds. The intention is to diversify Oxurion’s property by specializing in cryptocurrencies resembling Bitcoin and Ethereum.
This financing is a part of a long-term funding technique aimed toward strengthening Oxurion’s place within the digital markets. The tranches might be launched sequentially, contingent upon the conversion of earlier bonds. A primary-lien lien is secured towards the digital property to ensure these transactions.
